Completed NA INTERVENTIONAL 2-arm NCT01084499

Bioequivalence Study of Letrozole 2.5 mg Tablets

Bioequivalence Study of YUHAN Letrozole 2.5 mg Tablets

Sponsor: Yuhan Corporation

Conditions Healthy

Interventions Femara (Sequence 1) Femara (Sequence 2) Peratra (Sequence 1) Peratra (Sequence 2)

Updated 8 times since 2017 Last updated: Mar 26, 2019 Started: Jan 31, 2009 Primary completion: Apr 30, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01084499, this NA trial focuses on Healthy and remains completed. Sponsored by Yuhan Corporation, it has been updated 8 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 3 earlier versions

Apr 2019 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Apr 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yuhan Corporation

Data source: Yuhan Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.